Compare Humana Inc (HUM) vs The Coca-Cola Co K (KO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs The Coca-Cola Co K — how do they compare? Humana Inc trades at $375 (market cap $46.31B), while The Coca-Cola Co K trades at $86.62 (market cap $373.76B). The key difference: The Coca-Cola Co K is far larger — about 8.1× Humana Inc's market cap, and The Coca-Cola Co K pays the higher dividend (2.44%). Which is the better fit depends on your goals.
| HUM | KO | |
|---|---|---|
Market Cap | $46.31B | $373.76B |
Sector | Health | Consumer Staples |
52-Week High | $409.42 | $89.08 |
52-Week Low | $163.67 | $65.67 |
Enterprise Value | $53.67B | $400.93B |
Dividend Yield | 0.92% | 2.44% |
Volume | — | 14,630,257 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
Coca-Cola (KO) trades at $86.79, down slightly by 0.3% on the day, with a bullish technical signal and strong fundamental performance. The stock exhibits robust profitability with a net income margin of 28.56% and has beaten earnings estimates for the last three quarters. Recent news highlights institutional buying and stable demand trends, while the company maintains a 64-year dividend growth streak, reinforcing its defensive appeal.
The outlook for KO remains positive, supported by consistent earnings beats, a high analyst buy rating (60%), and a consensus price target of $95.83 implying ~10% upside. Key risks include regional demand divergence and high debt levels, but the stock's quality fundamentals and dividend reliability offer a compelling case for long-term investors amid market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →
